event
-
Vorapaxar’s data presented at AHA, published in NEJM
Researchers presented and published results from TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome), the first clinical outcomes trial of vorapaxar, the investigational Protease Activated Receptor 1 (PAR-1) thrombin receptor antagonist from Merck (known as MSD outside the US and Canada).
event | 18 November 2011
-
New data presented on phase 3 trial Of ELIQUIS (apixaban) in the prevention of venous thromboembolism in patients with acute medical illness
Bristol-Myers Squibb and Pfizer announced the results of the Phase 3 ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial, which evaluated apixaban versus enoxaparin in acutely ill medical patients, did not meet the primary efficacy outcome of superiority to enoxaparin for the endpoint of venous thromboembolism (VTE) and VTE-related death at day 30.
event | 15 November 2011
-
Cognex participates in virtual event
Online conference and trade show addresses one of the key issues facing the supply chain in Pharma and BioPharma — fake drugs.
event | 13 September 2011
-
Abbott named to Dow Jones Sustainability Indexes for seventh consecutive year
Receives recognition of leading corporate citizenship performance.
event | 09 September 2011
-
Prototype Vaccine to Prevent Breast Cancer
Researchers at Cleveland Clinic's Lerner Research Institute say they have developed prototype vaccine to prevent breast cancer. The research can lead to prevention in women over age 40 and those at high risk. The vaccine has shown favorable results i…
event | 09 June 2010
-
Novartis Receives Approval for Organ Rejection Prevention Drug
The US Food and Drug Administration (FDA) has approved Zortress (everolimus) oral tablets for the prevention of organ rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. The drug is to be given in combination with r…
event | 27 May 2010
-
Werum to Host MES Event in China
On March 31, Bayer Technology & Engineering (Shanghai) [BTES] and Werum Software & Systems will host the PAS-X Manufacturing Execution System (MES) Day for the pharmaceutical industry in China. This one-day MES conference gives guidance on the qu…
event | 17 February 2010
-
Singapore to Host Healthcare Event
From March 30-31, Economist Conferences will host the inaugural Healthcare in Asia event in Singapore. The roundtable is part of a multi-year initiative and the theme of the first year’s forum is “The healthcare challenges in Asia, and the priori…
event | 04 February 2010
-
Bilberry Extract Shows Positive Results for Cancer Treatment
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect has been presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the…
event | 10 December 2009
-
PPD to Evaluate US FDA Public Health Surveillance System
PPD has been awarded a contract by the US Food and Drug Administration (FDA) to evaluate the agency's Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. The company will conduct an evaluation…
event | 03 December 2009
